WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
Husband saw his wife, 50, die trying to save their beloved Labrador from a fastAthletes tied to Iowa gambling sting seek damages in civil lawsuit against state and investigatorsBiden administration postpones ban on mentholBook Review: Emily Henry is still the modernNew York to require internet providers to charge lowI have £300,000 invested in a pensionAP Week in Pictures: North AmericaChasing ‘Twisters’ and collaborating with ‘tornado fanatic’ Steven SpielbergRevealed: The 10 surprising foods experts say you should keep in the fridgeJudge upholds disqualification of challenger to judge in Trump’s Georgia election interference case